GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rainmed Medical Ltd (HKSE:02297) » Definitions » ROA %

Rainmed Medical (HKSE:02297) ROA % : -14.08% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Rainmed Medical ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Rainmed Medical's annualized Net Income for the quarter that ended in Jun. 2024 was HK$-89.67 Mil. Rainmed Medical's average Total Assets over the quarter that ended in Jun. 2024 was HK$636.93 Mil. Therefore, Rainmed Medical's annualized ROA % for the quarter that ended in Jun. 2024 was -14.08%.

The historical rank and industry rank for Rainmed Medical's ROA % or its related term are showing as below:

HKSE:02297' s ROA % Range Over the Past 10 Years
Min: -205.95   Med: -186.11   Max: -17.96
Current: -17.96

During the past 4 years, Rainmed Medical's highest ROA % was -17.96%. The lowest was -205.95%. And the median was -186.11%.

HKSE:02297's ROA % is ranked worse than
68.32% of 865 companies
in the Medical Devices & Instruments industry
Industry Median: -1.04 vs HKSE:02297: -17.96

Rainmed Medical ROA % Historical Data

The historical data trend for Rainmed Medical's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rainmed Medical ROA % Chart

Rainmed Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROA %
-205.95 -178.88 -193.34 -18.13

Rainmed Medical Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROA % Get a 7-Day Free Trial -376.23 -40.55 -13.90 -22.13 -14.08

Competitive Comparison of Rainmed Medical's ROA %

For the Medical Devices subindustry, Rainmed Medical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rainmed Medical's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rainmed Medical's ROA % distribution charts can be found below:

* The bar in red indicates where Rainmed Medical's ROA % falls into.


;
;

Rainmed Medical ROA % Calculation

Rainmed Medical's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-126.692/( (770.902+627.072)/ 2 )
=-126.692/698.987
=-18.13 %

Rainmed Medical's annualized ROA % for the quarter that ended in Jun. 2024 is calculated as:

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=-89.668/( (627.072+646.781)/ 2 )
=-89.668/636.9265
=-14.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2024) net income data. ROA % is displayed in the 30-year financial page.


Rainmed Medical  (HKSE:02297) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=-89.668/636.9265
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-89.668 / 57.85)*(57.85 / 636.9265)
=Net Margin %*Asset Turnover
=-155 %*0.0908
=-14.08 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Rainmed Medical ROA % Related Terms

Thank you for viewing the detailed overview of Rainmed Medical's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rainmed Medical Business Description

Traded in Other Exchanges
N/A
Address
No. 99, Jinji Lake Avenue, Building 31, Northeast District, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000
Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company's core products, the caFFR system and the caIMR system are medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). It operates in China and Other countries.
Executives
Huo Yunfei 2101 Beneficial owner
Huo Yunlong
Zhou Bin
Zhong Guo Ping An Bao Xian Ji Tuan Gu Fen You Xian Gong Si
Xi Zang Jing Jia Qi Ye Guan Li You Xian Ze Ren Gong Si
Shang Hai Jing Lin Gu Quan Tou Zi Guan Li You Xian Gong Si
Shang Hai Jing Wu Tou Zi Zhong Xin You Xian He Huo
Shang Hai Jing Mai Run Qi Ye Guan Li Zhong Xin You Xian He Huo
Gong Qing Cheng Jing Cheng Yu Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Gong Qing Cheng Jing Lin Jing Jia Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Jing Lin Zi Ben Guan Li You Xian Gong Si
Shen Zhen Jing Lin Jing Ying Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Shen Zhen Jing Hui Gu Quan Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Shang Hai Tong Xiang Hao Qian Qi Ye Guan Li He Huo Qi Ye You Xian He Huo
Xi Zang Jing Ning Qi Ye Guan Li You Xian Ze Ren Gong Si

Rainmed Medical Headlines

No Headlines